MindX Sciences Logo

News

Indianapolis, IN, June 3, 2021 — MindX Sciences has established a Mental Health Transformation Advisory Board, which will be led by Dr. Jerome Adams, the former Surgeon General of the United States. He will provide strategic advice on maximizing societal impact, addressing health disparities, and helping improve military mental health. Dr. Adams is also a practicing anesthesiologist, and has a strong interest and expertise in pain treatments and addictions.

A blood test may help the diagnosis and treatment of depression.  The Economist — May 3, 2021

MindX Sciences Aims to Bring Objectivity to Psychiatric Disorder Testing With RNA Expression Markers.  GenomeWeb — April 28, 2021

Panel of 26 Biomarkers May Allow for Precision Medicine Treatment Plans Among Patients With Mood Disorders.  PsychiatryAdvisor — April 26, 2021

Indianapolis, April 26, 2021 — MindX Sciences is proud to announce a partnership with Q2, a premier genomics lab.  View more...

Can a Blood Test Diagnose Depression?  HealthyWomen — April 20, 2021

Researchers develop blood test that could help gauge depression, bipolar disorder.  FOX5 New York — April 12, 2021

Bientôt un test sanguin pour détecter la dépression et le trouble bipolaire?  Pourqui Docteur — 11.04.2021

Researchers Develop Biomarker Blood Test for Depression, Bipolar Disorder.  Genetic Engineering & Biotechnology News — April 9, 2021

Indianapolis, IN, April 8th, 2021 — IU School of Medicine researchers develop blood test for depression, bipolar disorder.  View more...

Indianapolis, IN, March 9th, 2021 — Dr. Christopher Reist, an authority on PTSD and clinical trials, joined the Scientific Advisory Board (SAB) of MindX Sciences.

Indianapolis, IN, March 8th, 2021 — Dr. Alexander Niculescu gave a talk on “Precision Medicine for Mood Disorders”, an upcoming publication, at the annual invitation-only Translational Psychiatry meeting in Park City, Utah, this year held in a virtual format.

Indianapolis, IN, February 26th, 2021 — The United States Patent Office granted Patent Application No. 15/735,304 titled: PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT, licensed by MindX Sciences from Indiana University.

Can An Indy Startup Conquer Mental Health’s Final Frontier?  Indianapolis Monthly, March 2021